caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1841231545

Reza NaghaviM.D.

PRACTICER.S. NAGHAVI, M.D. PLLCSee all providers at this practice →
Internal MedicineRockville Centre, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
3,223
Unique beneficiaries
—
Total services
6,003
Distinct HCPCS
40
Medicare payment
$392K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 7,864 Internal Medicine providers in NY — top quintile (cohort median 552).
REFERRAL NETWORK

Where Reza Naghavi's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Bioreference Health, Llc
Clinical Laboratory · Elmwood Park, NJ
2334,290
Mohammad Mukhtar
Family Practice · Rockville Centre, NY
191760
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Melville, NY
38270
NORTH SHORE UNIVERSITY HOSPITAL2163
Sunrise Medical Laboratories, Inc.
Clinical Laboratory · Hicksville, NY
1561
Raul Mendoza
Cardiology · Lawrence, NY
1437
NYU LANGONE HOSPITALS1445
Tarek Mousa
Internal Medicine · Astoria, NY
1347
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
QUALITY · MIPS · 2024
Final MIPS score
32.4
Quality
15.0
Cost
84.0
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
-5.11%
Individual
PRESCRIBING · PART D · 2024
Total Rx claims
11,295
Beneficiaries
—
Total drug cost
$1.2M
Distinct drugs
145
Brand share
25.6%
Top prescribed drugs
Famotidine524 claims
Lidocaine435 claims
Atorvastatin Calcium414 claims
Diclofenac Sodium409 claims
Meloxicam378 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$543
Payment records
21
By payment type
Food and Beverage$543